HB-1614

Asset

Inhibits hyaluronan synthesis to reduce inflammatory, fibrotic, and metabolic signaling.

Stage
Stage not known
Modality
Small molecule
Target
Not known
0
Indications
0
Trials
1
Developer

Indications

0

    In the full profile

    • Owner and partners1

    Every asset’s record: target, stage, trials and the evidence behind it.

    See Pro

    Assets